Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant setting.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Oct 2008

Lok Anna S F

Abstract excerpt

1. Hepatitis B virus variants with antiviral drug-resistant mutations and/or hepatitis B immune globulin-resistant mutations are the main cause of hepatitis B virus reinfections post-liver transplant. 2. Early diagnosis of antiviral drug resistance and prompt initiation of rescue therapy are important in preventing hepatitis flares and hepatic decompensation. 3. Virologic breakthrough is the first indication of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis B

Share to Hepatitis B virus

Share to Liver Transplantation

Share to Mutation

Source

Identifiers

PMID: 18825720
DOI: 10.1002/lt.21616

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant setting.PMID 18825720Read ↗

Management of antiviral drug resistance in chronic hepatitis B.Semantic proximity Read ↗

Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance.Semantic proximity Read ↗

Antiviral‐resistant hepatitis B virus: can we prevent this monster from growing?Semantic proximity Read ↗

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.Semantic proximity Read ↗

Chronic hepatitis B: preventing, detecting, and managing viral resistance.Semantic proximity Read ↗

Treatment for hepatitis B in patients with drug resistanceSemantic proximity Read ↗

Analysis of the prevalence of drug-resistant hepatitis B virus in patients with antiviral therapy failure in a Chinese tertiary referral liver centre (2010-2014).Semantic proximity Read ↗

Antiviral drug resistance testing in patients with chronic hepatitis B.Semantic proximity Read ↗

Antiviral drug resistance: clinical consequences and molecular aspects.Semantic proximity Read ↗

Prevention and management of drug resistance for antihepatitis B treatment.Semantic proximity Read ↗

Drug resistance in antiviral therapy.Semantic proximity Read ↗

Management and prevention of drug resistance in chronic hepatitis B.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.